AEON – Trajectories of Longevity and CRISPR-Cas

AEON – Trajectories of Longevity and CRISPR-Cas

First European artist residency and exhibition on the topic of CRISPR-Cas

Selected amongst over 40 proposals received through STATE's Open Call, Finnish artist and designer Emilia Tikka spent two months at the Max Delbrück Center for Molecular Medicine (MDC). There, she worked on uncovering the molecular hallmarks of aging together with the researchers. In an intensive exchange with the scientists at MDC, the artist-in-residence explored the potential of the CRISPR/dCAS9 technology to reverse the biological clock. ÆON- Trajectories of Longevity and CRISPR - addresses philosophical and societal dimensions of the desire for eternal life.

Together with STATE Studio, Tikka gave a sneak preview of the preliminary design to visitors of Ars Electronica 2018. ÆON- Trajectories of Longevity and CRISPR premiered at STATE Studio October 2018.

Role: Concept and program, development, organization of partners, international open call, organization of legal frameworks, residency period at research institute, exhibition production, press and communications

The artist residency was funded by the EU ORION Open Science Project, which aims to engage society in discussions of the risks and opportunities presented by disruptive technologies. This project was funded by European Union’s Horizon 2020 research and innovation programme under grant agreement No 741527.

Partner